ARCHIVES

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

Docetaxel, Oxaliplatin Active Against Esophageal Cancer

June 30, 2006

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

Cooperative Groups: PCPT Enrollment Complete, Three Years To The Day rial Began

December 13, 1996

Suit Against Craig Thompson Settled As Company He Co-Founded Licenses “Newly Identified” Discoveries From UPenn

September 14, 2012

NCI Forms New Committees to Oversee Cancer Clinical Trials.

February 17, 2006